Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENFORCE trial of peri-operative testosterone replacement after radical prostatectomy
NL-OMON52940Phase 3Recruiting
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Hypoandrogenism (TD) and Hypogonadism comparing Testosterone gel with Placebo gel (2 arms). Started Jan 2023; status: recruiting.
02
Drugs
testosterone
03
Conditions
Hypoandrogenism (TD)Hypogonadism
Beyond the preview
Go deeper on NL-OMON52940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52940.